Pneumococcal Conjugate Vaccine (PCV) Market, Global Outlook and Forecast 2023-2029

Report ID: MMG97762 | Category: Pharma & Healthcare | Pages: 61 | Format: PDF | Published Date: July 12,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$3250.00 Multi User-$4225.00

Report Description
View Table of Contents

Report Summary

This report aims to provide a comprehensive presentation of the global market for Pneumococcal Conjugate Vaccine (PCV), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pneumococcal Conjugate Vaccine (PCV). This report contains market size and forecasts of Pneumococcal Conjugate Vaccine (PCV) in global, including the following market information:
Global Pneumococcal Conjugate Vaccine (PCV) Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Pneumococcal Conjugate Vaccine (PCV) market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
23-valent Vaccine Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Pneumococcal Conjugate Vaccine (PCV) include Pfizer, GSK, Sanofi, Merck, Walvax Biotechnology, Royal (Wuxi) Bio-Pharmaceutical, Zhifei Biologic and Serum Institute of India, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Pneumococcal Conjugate Vaccine (PCV) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pneumococcal Conjugate Vaccine (PCV) Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Pneumococcal Conjugate Vaccine (PCV) Market Segment Percentages, by Type, 2022 (%)
    23-valent Vaccine
    10-valent Vaccine
    7-valent Vaccine
    13-valent Vaccine
Global Pneumococcal Conjugate Vaccine (PCV) Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Pneumococcal Conjugate Vaccine (PCV) Market Segment Percentages, by Application, 2022 (%)
    Child
    Adult
Global Pneumococcal Conjugate Vaccine (PCV) Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Pneumococcal Conjugate Vaccine (PCV) Market Segment Percentages, By Region and Country, 2022 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pneumococcal Conjugate Vaccine (PCV) revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Pneumococcal Conjugate Vaccine (PCV) revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
    Pfizer
    GSK
    Sanofi
    Merck
    Walvax Biotechnology
    Royal (Wuxi) Bio-Pharmaceutical
    Zhifei Biologic
    Serum Institute of India
Outline of Major Chapters:
Chapter 1: Introduces the definition of Pneumococcal Conjugate Vaccine (PCV), market overview.
Chapter 2: Global Pneumococcal Conjugate Vaccine (PCV) market size in revenue.
Chapter 3: Detailed analysis of Pneumococcal Conjugate Vaccine (PCV) company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Pneumococcal Conjugate Vaccine (PCV) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

1 Introduction to Research & Analysis Reports
    1.1 Pneumococcal Conjugate Vaccine (PCV) Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Pneumococcal Conjugate Vaccine (PCV) Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Pneumococcal Conjugate Vaccine (PCV) Overall Market Size
    2.1 Global Pneumococcal Conjugate Vaccine (PCV) Market Size: 2022 VS 2029
    2.2 Global Pneumococcal Conjugate Vaccine (PCV) Market Size, Prospects & Forecasts: 2018-2029
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Pneumococcal Conjugate Vaccine (PCV) Players in Global Market
    3.2 Top Global Pneumococcal Conjugate Vaccine (PCV) Companies Ranked by Revenue
    3.3 Global Pneumococcal Conjugate Vaccine (PCV) Revenue by Companies
    3.4 Top 3 and Top 5 Pneumococcal Conjugate Vaccine (PCV) Companies in Global Market, by Revenue in 2022
    3.5 Global Companies Pneumococcal Conjugate Vaccine (PCV) Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Pneumococcal Conjugate Vaccine (PCV) Players in Global Market
        3.6.1 List of Global Tier 1 Pneumococcal Conjugate Vaccine (PCV) Companies
        3.6.2 List of Global Tier 2 and Tier 3 Pneumococcal Conjugate Vaccine (PCV) Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Pneumococcal Conjugate Vaccine (PCV) Market Size Markets, 2022 & 2029
        4.1.2 23-valent Vaccine
        4.1.3 10-valent Vaccine
        4.1.4 7-valent Vaccine
        4.1.5 13-valent Vaccine
    4.2 By Type - Global Pneumococcal Conjugate Vaccine (PCV) Revenue & Forecasts
        4.2.1 By Type - Global Pneumococcal Conjugate Vaccine (PCV) Revenue, 2018-2023
        4.2.2 By Type - Global Pneumococcal Conjugate Vaccine (PCV) Revenue, 2024-2029
        4.2.3 By Type - Global Pneumococcal Conjugate Vaccine (PCV) Revenue Market Share, 2018-2029
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Pneumococcal Conjugate Vaccine (PCV) Market Size, 2022 & 2029
        5.1.2 Child
        5.1.3 Adult
    5.2 By Application - Global Pneumococcal Conjugate Vaccine (PCV) Revenue & Forecasts
        5.2.1 By Application - Global Pneumococcal Conjugate Vaccine (PCV) Revenue, 2018-2023
        5.2.2 By Application - Global Pneumococcal Conjugate Vaccine (PCV) Revenue, 2024-2029
        5.2.3 By Application - Global Pneumococcal Conjugate Vaccine (PCV) Revenue Market Share, 2018-2029
6 Sights by Region
    6.1 By Region - Global Pneumococcal Conjugate Vaccine (PCV) Market Size, 2022 & 2029
    6.2 By Region - Global Pneumococcal Conjugate Vaccine (PCV) Revenue & Forecasts
        6.2.1 By Region - Global Pneumococcal Conjugate Vaccine (PCV) Revenue, 2018-2023
        6.2.2 By Region - Global Pneumococcal Conjugate Vaccine (PCV) Revenue, 2024-2029
        6.2.3 By Region - Global Pneumococcal Conjugate Vaccine (PCV) Revenue Market Share, 2018-2029
    6.3 North America
        6.3.1 By Country - North America Pneumococcal Conjugate Vaccine (PCV) Revenue, 2018-2029
        6.3.2 US Pneumococcal Conjugate Vaccine (PCV) Market Size, 2018-2029
        6.3.3 Canada Pneumococcal Conjugate Vaccine (PCV) Market Size, 2018-2029
        6.3.4 Mexico Pneumococcal Conjugate Vaccine (PCV) Market Size, 2018-2029
    6.4 Europe
        6.4.1 By Country - Europe Pneumococcal Conjugate Vaccine (PCV) Revenue, 2018-2029
        6.4.2 Germany Pneumococcal Conjugate Vaccine (PCV) Market Size, 2018-2029
        6.4.3 France Pneumococcal Conjugate Vaccine (PCV) Market Size, 2018-2029
        6.4.4 U.K. Pneumococcal Conjugate Vaccine (PCV) Market Size, 2018-2029
        6.4.5 Italy Pneumococcal Conjugate Vaccine (PCV) Market Size, 2018-2029
        6.4.6 Russia Pneumococcal Conjugate Vaccine (PCV) Market Size, 2018-2029
        6.4.7 Nordic Countries Pneumococcal Conjugate Vaccine (PCV) Market Size, 2018-2029
        6.4.8 Benelux Pneumococcal Conjugate Vaccine (PCV) Market Size, 2018-2029
    6.5 Asia
        6.5.1 By Region - Asia Pneumococcal Conjugate Vaccine (PCV) Revenue, 2018-2029
        6.5.2 China Pneumococcal Conjugate Vaccine (PCV) Market Size, 2018-2029
        6.5.3 Japan Pneumococcal Conjugate Vaccine (PCV) Market Size, 2018-2029
        6.5.4 South Korea Pneumococcal Conjugate Vaccine (PCV) Market Size, 2018-2029
        6.5.5 Southeast Asia Pneumococcal Conjugate Vaccine (PCV) Market Size, 2018-2029
        6.5.6 India Pneumococcal Conjugate Vaccine (PCV) Market Size, 2018-2029
    6.6 South America
        6.6.1 By Country - South America Pneumococcal Conjugate Vaccine (PCV) Revenue, 2018-2029
        6.6.2 Brazil Pneumococcal Conjugate Vaccine (PCV) Market Size, 2018-2029
        6.6.3 Argentina Pneumococcal Conjugate Vaccine (PCV) Market Size, 2018-2029
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Pneumococcal Conjugate Vaccine (PCV) Revenue, 2018-2029
        6.7.2 Turkey Pneumococcal Conjugate Vaccine (PCV) Market Size, 2018-2029
        6.7.3 Israel Pneumococcal Conjugate Vaccine (PCV) Market Size, 2018-2029
        6.7.4 Saudi Arabia Pneumococcal Conjugate Vaccine (PCV) Market Size, 2018-2029
        6.7.5 UAE Pneumococcal Conjugate Vaccine (PCV) Market Size, 2018-2029
7 Pneumococcal Conjugate Vaccine (PCV) Companies Profiles
    7.1 Pfizer
        7.1.1 Pfizer Company Summary
        7.1.2 Pfizer Business Overview
        7.1.3 Pfizer Pneumococcal Conjugate Vaccine (PCV) Major Product Offerings
        7.1.4 Pfizer Pneumococcal Conjugate Vaccine (PCV) Revenue in Global Market (2018-2023)
        7.1.5 Pfizer Key News & Latest Developments
    7.2 GSK
        7.2.1 GSK Company Summary
        7.2.2 GSK Business Overview
        7.2.3 GSK Pneumococcal Conjugate Vaccine (PCV) Major Product Offerings
        7.2.4 GSK Pneumococcal Conjugate Vaccine (PCV) Revenue in Global Market (2018-2023)
        7.2.5 GSK Key News & Latest Developments
    7.3 Sanofi
        7.3.1 Sanofi Company Summary
        7.3.2 Sanofi Business Overview
        7.3.3 Sanofi Pneumococcal Conjugate Vaccine (PCV) Major Product Offerings
        7.3.4 Sanofi Pneumococcal Conjugate Vaccine (PCV) Revenue in Global Market (2018-2023)
        7.3.5 Sanofi Key News & Latest Developments
    7.4 Merck
        7.4.1 Merck Company Summary
        7.4.2 Merck Business Overview
        7.4.3 Merck Pneumococcal Conjugate Vaccine (PCV) Major Product Offerings
        7.4.4 Merck Pneumococcal Conjugate Vaccine (PCV) Revenue in Global Market (2018-2023)
        7.4.5 Merck Key News & Latest Developments
    7.5 Walvax Biotechnology
        7.5.1 Walvax Biotechnology Company Summary
        7.5.2 Walvax Biotechnology Business Overview
        7.5.3 Walvax Biotechnology Pneumococcal Conjugate Vaccine (PCV) Major Product Offerings
        7.5.4 Walvax Biotechnology Pneumococcal Conjugate Vaccine (PCV) Revenue in Global Market (2018-2023)
        7.5.5 Walvax Biotechnology Key News & Latest Developments
    7.6 Royal (Wuxi) Bio-Pharmaceutical
        7.6.1 Royal (Wuxi) Bio-Pharmaceutical Company Summary
        7.6.2 Royal (Wuxi) Bio-Pharmaceutical Business Overview
        7.6.3 Royal (Wuxi) Bio-Pharmaceutical Pneumococcal Conjugate Vaccine (PCV) Major Product Offerings
        7.6.4 Royal (Wuxi) Bio-Pharmaceutical Pneumococcal Conjugate Vaccine (PCV) Revenue in Global Market (2018-2023)
        7.6.5 Royal (Wuxi) Bio-Pharmaceutical Key News & Latest Developments
    7.7 Zhifei Biologic
        7.7.1 Zhifei Biologic Company Summary
        7.7.2 Zhifei Biologic Business Overview
        7.7.3 Zhifei Biologic Pneumococcal Conjugate Vaccine (PCV) Major Product Offerings
        7.7.4 Zhifei Biologic Pneumococcal Conjugate Vaccine (PCV) Revenue in Global Market (2018-2023)
        7.7.5 Zhifei Biologic Key News & Latest Developments
    7.8 Serum Institute of India
        7.8.1 Serum Institute of India Company Summary
        7.8.2 Serum Institute of India Business Overview
        7.8.3 Serum Institute of India Pneumococcal Conjugate Vaccine (PCV) Major Product Offerings
        7.8.4 Serum Institute of India Pneumococcal Conjugate Vaccine (PCV) Revenue in Global Market (2018-2023)
        7.8.5 Serum Institute of India Key News & Latest Developments
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Pneumococcal Conjugate Vaccine (PCV) Market, Global Outlook and Forecast 2023-2029

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?